MedTrace Logo

Long COVID Ultrasound Trial

NCT06189066 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2026-01-07

No results posted yet for this study

Summary

The research objective is to assess the safety and potential efficacy of spleen ultrasound stimulation as an intervention for Long COVID in a pilot study.

Specific Aims include:

* Measure Long COVID disease activity before, during and after an 8-week course of spleen-directed daily ultrasound stimulation.
* Measure molecular correlates of Long COVID disease activity before, during and after an 8-week course of spleen-directed daily ultrasound stimulation.
* Track adverse events throughout the study to assess safety of the ultrasound intervention.

Conditions

Interventions

DEVICE

Splenic Ultrasound

Daily ultrasound application to the spleen of approximately 18 minutes per day, 5 days per week for up to 8 weeks, in addition to standard clinical care.

Sponsors & Collaborators

  • University of Minnesota

    collaborator OTHER

  • MCDC (United States Department of Defense)

    collaborator UNKNOWN

  • SecondWave Systems Inc.

    lead INDUSTRY

Principal Investigators

  • Farha Ikramuddin, M.D. · University of Minnesota Medical School, Department of Rehabilitation Medicine

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-03
Primary Completion
2024-07-24
Completion
2025-07-24
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06189066 on ClinicalTrials.gov